New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 19, 2014
07:31 EDTNJR, WEST, RIBT, ENVI, RST, NNVC, MSEX, ANFC, DNR, ARCP, BRX, DRRXThe Wall Street Forum to hold a conference
25th Annual Investment Conference to be held in New York on June 19.
News For DNR;RST;NJR;ANFC;ENVI;DRRX;MSEX;RIBT;BRX;NNVC;WEST;ARCP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 18, 2014
07:39 EDTANFCCFA Society of Cleveland to hold a conference
Midwest Investment Conference to be held in Cleveland, Ohio on November 18.
07:28 EDTARCPRCS Capital shares still undervalued, says JMP Securities
Subscribe for More Information
06:05 EDTARCPAmerican Realty not in compliance with NASDAQ Listing Rule 5250
Subscribe for More Information
November 17, 2014
13:58 EDTDNRDenbury Resources price target lowered to $16 from $29 at Ladenburg
Subscribe for More Information
13:16 EDTDNRDenbury Resources down over 11%, near lows of session
Subscribe for More Information
12:27 EDTDNROn The Fly: Midday Wrap
Subscribe for More Information
10:02 EDTDNROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:45 EDTDNRDenbury Resources to host analyst day
Subscribe for More Information
08:45 EDTDNRDenbury Resources downgraded at Sterne Agee
As noted earlier, Sterne Agee downgraded Denbury to Neutral from Buy. The firm downgraded the stock based on the company's lower than expected 2015 dividend, cautious growth outlook, and two executive departures.
07:05 EDTNNVCNanoViricides says all drug development programs progressing satisfactorily
Subscribe for More Information
06:17 EDTDNRDenbury Resources downgraded to Neutral from Buy at Sterne Agee
Subscribe for More Information
05:50 EDTDNRDenbury Resources downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse downgraded Denbury Resources to Neutral citing lower oil prices and the recent resignation of two of the company's top operating officers. The firm lowered its price target for shares to $16 from $19.
November 14, 2014
16:36 EDTDNRDenbury Resources announces resignation of Craig McPherson as COO, FY15 plan
Subscribe for More Information
06:13 EDTARCPAmerican Realty receives lender waiver, extension for reporting Q3 results
Subscribe for More Information
November 13, 2014
12:00 EDTRIBTRiceBran management to meet with Maxim
Subscribe for More Information
11:00 EDTARCPStocks with call strike movement; ARCP BBRY
Subscribe for More Information
November 12, 2014
08:12 EDTANFCSeeThruEquity to hold a conference
Subscribe for More Information
06:13 EDTARCPAmerican Realty comments on litigation filed against RCS Capital
Subscribe for More Information
06:00 EDTBRXBrixmor Property 25M share Secondary priced at $23.75
Subscribe for More Information
November 11, 2014
16:09 EDTDRRXDURECT provides update on FDA communication over POSIDUR
DURECT announced that it has received meeting minutes from its face-to-face meeting with the FDA on September 23, regarding the POSIDUR program. In the February Complete Response Letter, the FDA indicated that multiple safety trials would be required to support a broad indication. DURECT inquired whether it would be possible to expedite approval by pursuing an initial indication of soft tissue post-surgical analgesia without conducting additional trials. The company said the FDA has indicated that in this scenario, it should be acceptable to conduct only one additional soft tissue clinical trial, the size of which is not yet defined, to generate the data required for product approval, including safety data for POSIDUR compared to a non-SABER containing comparator and also product efficacy. "Based on the Complete Response Letter we anticipated that we would be required to do additional safety trials," stated James Brown, President and CEO of DURECT. "Over the coming months, we expect to have further communications with the FDA to refine the path forward."
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use